FDA calendar · May 2020 · built from SEC filings

PDUFA dates May 2020: FDA calendar and catalysts.

Updated Snapshot 20261116T222116ZBuilt

0 PDUFA dates fell in May 2020. The FDA calendar also recorded 25 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.

PDUFA dates in May 2020

No PDUFA dates are disclosed for this period as of November 16, 2026.

Download: CSV · JSON · iCal (next 30 days, CC BY 4.0) · Calendar API · All months

May 2020: other FDA decisions and filings

DateDrugCompanyEventIndicationStatusSource
May 1, 2020Darzalex Faspro (daratumumab and hyaluronidase-fihj)JNJFDA approval—ApprovedopenFDA Drugs@FDA
May 5, 2020Farxiga (dapagliflozin)AZNLabel expansion—ApprovedopenFDA Drugs@FDA
May 6, 2020TABRECTA (capmatinib)NVSFDA approval—ApprovedopenFDA Drugs@FDA
May 8, 2020LYNPARZA® (olaparib)AZNLabel expansion—ApprovedopenFDA Drugs@FDA
May 8, 2020Retevmo (selpercatinib)LLYFDA approval—ApprovedopenFDA Drugs@FDA
May 13, 2020Faslodex (fulvestrant)AZNLabel expansion—ApprovedopenFDA Drugs@FDA
May 14, 2020Pomalyst (pomalidomide)BMYLabel expansion—ApprovedopenFDA Drugs@FDA
May 15, 2020Yervoy® (ipilimumab)BMYLabel expansion—ApprovedopenFDA Drugs@FDA
May 15, 2020Opdivo® (nivolumab)BMYLabel expansion—ApprovedopenFDA Drugs@FDA
May 19, 2020LYNPARZA® (olaparib)AZNLabel expansion—ApprovedopenFDA Drugs@FDA
May 21, 2020Cyclophosphamide (cyclophosphamide)RDYComplete Response Letter—CRL issuedFDA Complete Response Letters
May 22, 2020Phexx (citric acid; lactic acid; potassium bitartrate)EVFMFDA approval—ApprovedopenFDA Drugs@FDA
May 22, 2020ALUNBRIG (brigatinib)TAKLabel expansion—ApprovedopenFDA Drugs@FDA
May 23, 2020Tagrisso® (osimertinib)AZNLabel expansion—ApprovedopenFDA Drugs@FDA
May 26, 2020Yervoy® (ipilimumab)BMYLabel expansion—ApprovedopenFDA Drugs@FDA
May 26, 2020Opdivo® (nivolumab)BMYLabel expansion—ApprovedopenFDA Drugs@FDA
May 26, 2020Zosyn (piperacillin sodium; tazobactam sodium)PFELabel expansion—ApprovedopenFDA Drugs@FDA
May 26, 2020Ruxience (rituximab-pvvr)PFELabel expansion—ApprovedopenFDA Drugs@FDA
May 26, 2020Dupixent (dupilumab)REGNLabel expansion—ApprovedopenFDA Drugs@FDA
May 27, 2020Sirturo (bedaquiline fumarate)JNJLabel expansion—ApprovedopenFDA Drugs@FDA
May 28, 2020Brilinta (ticagrelor)AZNLabel expansion—ApprovedopenFDA Drugs@FDA
May 28, 2020MINOCIN® (minocycline)DERMFDA approval—ApprovedopenFDA Drugs@FDA
May 29, 2020Oriahnn (Copackaged) (elagolix sodium; elagolix sodium,estradiol,norethindrone acetate)ABBVFDA approval—ApprovedopenFDA Drugs@FDA
May 29, 2020Taltz (ixekizumab)LLYLabel expansion—ApprovedopenFDA Drugs@FDA
May 29, 2020Cyramza (ramucirumab)LLYLabel expansion—ApprovedopenFDA Drugs@FDA

May 2020: dated readouts

No events in this view.

Questions

What PDUFA dates are in May 2020?

0 PDUFA dates fell in May 2020. The FDA calendar also recorded 25 other catalysts that month, such as advisory committees and readouts, each quoted from the sponsor’s SEC filing or the FDA.

Can these dates change?

Yes. The FDA can extend a review by three months after a major amendment, and it sometimes acts before the goal date. Each row links the filing the date came from.

Built from primary public sources only: sponsor SEC filings (8-K, EX-99.1, 10-Q, 10-K), the FDA advisory committee calendar, FDA Novel Drug Approvals and Complete Response Letter records, openFDA, and ClinicalTrials.gov (U.S. National Library of Medicine). Every row links the sentence it came from. Dates move; the linked source is authoritative. Not investment or medical advice.

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.